ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,576,000 | +76.4% | 249,840 | -7.2% | 0.02% | -11.5% |
| Q1 2019 | $6,564,000 | -0.2% | 269,252 | -41.7% | 0.03% | -10.3% |
| Q4 2018 | $6,576,000 | -6.3% | 461,486 | 0.0% | 0.03% | +11.5% |
| Q3 2018 | $7,015,000 | -9.4% | 461,486 | 0.0% | 0.03% | -13.3% |
| Q2 2018 | $7,744,000 | -18.1% | 461,486 | -20.4% | 0.03% | -21.1% |
| Q1 2018 | $9,460,000 | +99.4% | 579,673 | +56.4% | 0.04% | +100.0% |
| Q4 2017 | $4,744,000 | -14.6% | 370,645 | -17.9% | 0.02% | -20.8% |
| Q3 2017 | $5,555,000 | -15.9% | 451,631 | -42.8% | 0.02% | -20.0% |
| Q2 2017 | $6,606,000 | +12.7% | 789,255 | +20.4% | 0.03% | +15.4% |
| Q1 2017 | $5,863,000 | -24.2% | 655,774 | -25.5% | 0.03% | -27.8% |
| Q4 2016 | $7,737,000 | +32.7% | 880,223 | +1.9% | 0.04% | +38.5% |
| Q3 2016 | $5,830,000 | -2.8% | 863,674 | -48.8% | 0.03% | -3.7% |
| Q2 2016 | $6,001,000 | +15.9% | 1,685,672 | -3.9% | 0.03% | +17.4% |
| Q1 2016 | $5,177,000 | -31.2% | 1,754,773 | -1.6% | 0.02% | -30.3% |
| Q4 2015 | $7,525,000 | +83.3% | 1,783,123 | +98.0% | 0.03% | +94.1% |
| Q3 2015 | $4,106,000 | -38.1% | 900,497 | -2.1% | 0.02% | -37.0% |
| Q2 2015 | $6,630,000 | -2.2% | 919,547 | 0.0% | 0.03% | -3.6% |
| Q1 2015 | $6,777,000 | +67.7% | 919,547 | +7.6% | 0.03% | +75.0% |
| Q4 2014 | $4,042,000 | – | 854,606 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MUFG Americas Holdings Corp | 36,200 | $71,000 | 0.00% |